echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Neurology: How effective is antiplatelet therapy for stroke after cerebral hemorrhage?

    JAMA Neurology: How effective is antiplatelet therapy for stroke after cerebral hemorrhage?

    • Last Update: 2021-09-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In high-income countries, at least one-third of adults who have strokes caused by spontaneous (non-traumatic) intracerebral hemorrhage (ICH) have been taking oral antithrombotic therapy due to their comorbidities and other risk factors for vascular diseases ( Antiplatelet or anticoagulant) medications .


    Vascular Thrombosis Myocardial Infarction

    Antiplatelet drugs may benefit survivors of spontaneous ICH, but their impact on major vascular events is uncertain


    RESTART included ICH survivors on antithrombotic therapy to estimate the impact of initiating and avoiding antiplatelet therapy on recurrent symptomatic ICH, and whether this risk may exceed any reduction in occlusive vascular events


    After a median follow-up of 537 participants for 2 years, the main results of RESTART ruled out all risks, but there was a very small increase in the risk of recurrence of ICH after antiplatelet therapy (adjusted hazard ratio [HR] , 0.




    prevention

    Participants were followed for up to 7 years for primary outcomes (recurrent symptomatic ICH) and secondary outcomes (all major vascular events)


    A total of 537 patients (median age, 76.


    The main result of recurrent ICH affected 22 of the 268 participants (8.


    Major vascular events affected 72 participants (26.


    Major vascular events affected 72 participants (26.


    This study found that antiplatelet therapy had no statistically significant effect on recurrent ICH or all major vascular events

    Original Source:



    Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.
    JAMA

    is here to leave a message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.